No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
201 |
4. Check minimum number of eventsNone |
201 |
5. Include endpoints |
256 |
6. Filter based on genotype QC (FinnGen only) |
216 |
Control definitions (FinnGen only)
- Control exclude
- D3_HAEMOLYTICANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D55-D59
- Name in latin
- Aliae anaemiae haemolyticae hereditariae
Similar endpoints
↥List of similar endpoints to
Other hereditary haemolytic anaemias
based on the number of shared cases.
Similar with more cases:
- Haemolytic anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2471 | 1228 | 1174 |
| Only index persons | 1959 | 1005 | 954 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 24.85 | 27.81 | 21.09 |
| Only index persons | 25.64 | 27.68 | 23.49 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 216 | 122 | 94 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 40.28 | 35.91 | 45.95 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 235
- Matched controls
- 2350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D58.2
ICD-10 Finland
Other haemoglobinopathies
+∞
84.6
76
*
D58.0
ICD-10 Finland
Hereditary spherocytosis
+∞
81.0
73
*
28200
ICD-8 Finland
Hereditary haemolytic anaemias, Familial acholuric jaundice
+∞
35.3
33
*
D58.9
ICD-10 Finland
Hereditary haemolytic anaemia, unspecified
+∞
22.2
21
*
2820A
ICD-9 Finland
Hereditary haemolytic anaemias, Hereditary spherocytosis
+∞
19.0
18
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.9
17.9
45
109
D58.8
ICD-10 Finland
Other specified hereditary haemolytic anaemias
+∞
14.7
14
*
D58.1
ICD-10 Finland
Hereditary elliptocytosis
+∞
14.7
14
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
+∞
12.6
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
11.4
37
108
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
+∞
10.5
10
*
D75.1
ICD-10 Finland
Secondary polycythaemia
104.0
9.5
10
*
28299
ICD-8 Finland
Hereditary haemolytic anaemias, Other
+∞
9.4
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
9.1
48
189
WW500
NOMESCO Finland
Blood transfusion
5.2
8.5
18
37
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.9
7.5
38
146
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
82.6
7.5
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
7.1
76
415
JMA10
NOMESCO Finland
Transabdominal total splenectomy
17.3
6.8
10
6
XW000
NOMESCO Finland
Bone marrow biopsy
6.5
6.6
16
26
D50.8
ICD-10 Finland
Other iron deficiency anaemias
18.6
6.3
9
5
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
18.6
6.3
9
5
6753
FHL
Transabdominal splenectomy
+∞
6.3
6
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
80
12.28
60.88
4.3
1.5
0.75
1.53
g/l
6.47
51
70
39
43
10.68
33.08
2.3
1.5
—
—
—
0
0
129
516
4.33
27.64
3.6
2.3
4.65
2.81
mg/l
3.25
118
446
183
1189
3.44
14.63
16.5
10.1
4.53
4.06
e9/l
1.62
166
1040
164
1020
3.01
13.77
5.6
3.1
171.86
101.55
ug/l
3.71
157
968
170
1085
3.05
13.48
14.0
6.4
19.18
11.28
umol/l
8.01
165
1029
72
291
3.13
13.47
1.9
1.6
1205.69
1231.73
nmol/l
0.08
61
219
16
6
28.44
12.21
2.4
1.0
—
—
—
0
0
16
6
28.44
12.21
2.4
1.0
—
—
—
0
0
23
29
8.67
10.89
1.1
1.1
—
—
—
0
0
137
856
2.44
10.10
7.7
5.1
37.28
36.30
g/l
1.16
131
814
99
543
2.42
9.68
2.4
1.6
22.07
21.40
nmol/l
0.18
89
462
92
522
2.25
8.01
3.5
2.8
333.27
340.80
umol/l
0.29
79
466
50
218
2.64
7.77
3.7
4.6
6.00
5.75
kpa
1.16
50
210
134
899
2.14
7.49
8.3
6.5
1.21
1.22
mmol/l
0.37
127
841
80
452
2.17
6.86
5.1
1.8
1.09
1.18
mg/l
0.16
65
346
44
191
2.60
6.86
3.3
3.8
4.11
4.53
kpa
0.82
44
184
125
839
2.05
6.74
2.5
2.0
87.60
97.09
pmol/l
1.91
74
426
140
994
2.01
6.29
8.0
7.3
1.21
1.21
mmol/l
0.35
126
869
17
44
4.09
6.10
1.4
1.2
6.00
4.32
u/ml
0.19
12
19
192
1548
2.31
5.93
14.4
8.0
75.37
79.51
u/l
0.93
187
1464
52
262
2.26
5.82
7.5
8.1
104.17
104.19
mmol/l
0.01
52
262
68
385
2.08
5.66
3.2
2.7
2.43
2.45
mmol/l
0.51
59
346
9
7
13.30
5.63
8.9
1.4
212.33
200.71
u/l
—
9
7
44
213
2.31
5.38
7.0
8.9
0.87
0.79
mmol/l
0.04
37
180
16
44
3.83
5.30
1.7
2.7
1.38
1.48
ratio
—
9
18
15
32
4.93
5.09
1.2
1.4
—
—
—
0
0
15
32
4.93
5.09
1.2
1.4
—
—
—
0
0
13
25
5.44
4.84
2.2
1.3
30.77
32.80
pg
0.40
13
25
43
216
2.21
4.80
7.0
8.8
5.08
5.14
kpa
0.18
43
208
43
216
2.21
4.80
7.0
8.7
13.69
12.89
kpa
0.29
43
209
37
176
2.31
4.70
7.1
8.5
1.22
1.30
mmol/l
0.24
37
171
54
302
2.02
4.57
3.2
2.3
29.74
29.29
s
0.21
54
297
32
145
2.40
4.52
8.5
9.9
25.48
24.81
mmol/l
0.46
32
145
41
209
2.16
4.41
3.8
2.5
28.72
30.68
u/l
0.29
36
170
9
13
7.15
4.20
1.3
1.4
—
—
—
0
0
15
47
3.34
4.13
1.2
1.7
—
—
—
0
0
20
75
2.82
4.11
1.5
1.6
13.27
7.37
u/l
0.72
15
58
50
284
1.97
4.02
5.4
6.2
1.05
1.09
mmol/l
0.42
50
262
80
534
1.76
3.85
5.9
3.4
1442.50
1024.24
ng/l
0.38
71
442
14
44
3.32
3.84
1.4
1.5
—
—
—
0
0
14
45
3.24
3.71
1.2
1.7
164.22
148.95
u/ml
—
9
20
41
227
1.98
3.53
2.4
1.7
—
—
—
0
0
8
13
6.33
3.53
3.3
2.4
—
—
—
0
0
98
707
1.66
3.49
3.8
3.3
2.38
2.36
mmol/l
0.80
87
653
7
10
7.17
3.38
2.6
1.9
11.86
10.50
umol/l
—
7
10
17
65
2.74
3.38
1.5
1.4
—
—
—
0
0
23
104
2.34
3.28
3.4
3.1
0.48
0.62
%
1.28
23
104
14
49
2.97
3.25
1.3
1.3
—
—
—
0
0
41
239
1.87
3.03
2.3
1.7
—
—
—
0
0
34
187
1.96
2.99
4.0
4.8
2.60
32.70
ug/l
0.70
26
150
9
23
4.03
2.80
1.8
1.3
—
—
—
0
0
26
133
2.07
2.78
1.6
1.5
—
—
—
0
0
6
10
6.12
2.71
2.7
2.3
383.83
1009.70
u/ml
—
6
10
12
41
3.03
2.66
1.2
1.1
—
—
—
0
0
119
943
1.53
2.64
2.9
2.6
75.38
75.37
nmol/l
0.00
110
859
123
983
1.53
2.62
6.8
2.7
—
—
estimate
—
0
0
50
323
1.70
2.62
2.3
1.8
—
—
—
0
0
12
42
2.96
2.59
1.3
1.5
—
—
—
0
0
179
1560
1.62
2.53
5.5
4.3
11.45
10.08
mm/h
0.65
169
1455
78
571
1.55
2.45
3.2
3.2
0.34
0.28
e6/l
0.19
55
405
14
58
2.50
2.42
1.3
1.3
—
—
—
0
0
195
1752
1.66
2.26
33.4
17.8
14.69
13.49
%
10.54
195
1735
14
61
2.38
2.19
2.1
2.6
—
—
—
0
0
21
110
2.00
2.13
9.7
7.4
25.36
24.90
mmol/l
0.19
21
105
49
333
1.60
2.10
3.5
3.2
1.36
2.81
e6/l
0.97
25
164
10
37
2.78
2.09
1.4
1.3
—
—
—
0
0
5
11
4.62
1.95
1.2
1.3
215.20
440.33
u/l
—
5
11
6
16
3.82
1.94
1.0
1.0
—
—
—
0
0
28
168
1.76
1.91
13.1
8.0
8.77
7.96
mmol/l
0.21
28
163
51
360
1.53
1.85
1.7
1.8
386.00
38742185.48
pmol/l
0.50
42
302
178
1591
1.49
1.85
4.7
4.5
14.69
14.66
pmol/l
0.05
163
1461
5
12
4.23
1.83
1.0
1.2
—
—
—
0
0
12
54
2.29
1.77
1.3
1.5
—
—
—
0
0
7
24
2.97
1.73
3.0
1.5
—
—
—
0
0
26
161
1.69
1.61
2.6
2.7
82.70
67.22
ml/min/173m2
—
10
67
7
26
2.74
1.59
2.1
1.3
—
—
—
0
0
26
164
1.66
1.51
4.1
4.5
74.17
75.56
ng/l
0.04
21
146
18
102
1.83
1.49
2.2
1.6
—
—
—
0
0
65
503
1.40
1.47
7.9
2.4
—
—
—
0
0
204
1902
1.55
1.47
24.7
13.7
89.98
86.14
ml/min/173m2
1.65
194
1753
90
736
1.36
1.46
4.4
3.6
23.57
43.00
ng/l
1.38
57
492
12
59
2.09
1.46
7.2
3.0
0.67
2.43
index
—
6
35
5
16
3.17
1.44
1.6
1.3
86.80
105.63
pmol/l
—
5
16
18
106
1.76
1.34
3.1
2.2
7295.86
2044.73
u/l
—
7
34
49
367
1.42
1.33
3.4
3.3
66.43
445.22
ng/l
2.12
37
268
216
2050
1.66
1.32
27.4
14.3
21.12
22.37
mg/l
0.32
190
1665
71
568
1.36
1.31
1.3
1.3
0.72
1.52
u/ml
1.14
14
163
29
196
1.55
1.29
1.5
2.3
—
—
—
0
0
20
123
1.68
1.29
1.3
1.5
22.28
23.45
iu/l
0.05
12
102
191
1771
1.42
1.28
37.6
18.5
337.84
332.98
g/l
4.53
191
1765
5
19
2.67
1.22
1.2
1.2
—
—
—
0
0
11
57
1.98
1.19
1.9
1.6
—
—
—
0
0
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
15
88
1.75
1.14
2.1
1.3
—
—
—
0
0
47
361
1.38
1.11
3.4
3.1
0.35
0.87
e6/l
1.72
23
190
7
32
2.22
1.09
1.0
1.5
—
—
—
0
0
10
52
1.96
1.08
1.9
1.6
—
—
—
0
0
7
33
2.15
1.06
1.1
1.1
—
—
—
0
0
52
414
1.33
0.98
1.4
1.3
12.48
29.04
iu/ml
2.59
12
132
7
37
1.92
0.95
2.0
2.1
6.69
7.33
pmol/l
—
7
37
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
24
169
1.47
0.92
1.4
2.2
—
—
—
0
0
20
138
1.49
0.85
3.3
3.8
3.55
1.21
mmol/l
1.29
12
94
6
32
1.90
0.82
1.2
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
15.11
—
0
8
5
24
2.11
0.75
1.4
1.3
—
—
—
0
0
7
38
1.87
0.74
1.9
3.6
4.36
9.87
umol/l
—
7
29
7
38
1.87
0.74
1.1
1.1
—
—
—
0
0
78
889
0.82
0.74
2.3
2.0
1.28
1.40
mmol/l
0.53
67
755
9
56
1.63
0.73
2.0
1.4
—
—
—
0
0
5
26
1.94
0.71
2.0
1.3
—
—
—
0
0
47
387
1.27
0.71
1.4
1.3
10.07
8.36
u/ml
0.12
25
144
7
42
1.69
0.69
1.3
1.5
—
—
—
0
0
5
92
0.53
0.68
1.0
1.1
1.43
1.55
g/l
—
5
92
5
95
0.52
0.68
1.0
1.2
0.85
0.88
g/l
—
5
95
18
245
0.71
0.66
1.7
2.0
3.49
3.46
ratio
0.03
12
195
59
506
1.22
0.62
4.0
3.7
1.02
1.02
kg/l
0.16
38
330
195
1869
1.25
0.62
4.0
4.1
1.30
1.28
mmol/l
0.11
179
1736
0
21
0.00
0.60
0.0
4.6
—
84.80
—
0
21
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
26
203
1.32
0.59
4.7
3.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
55
476
1.20
0.54
1.7
1.7
—
—
—
0
0
14
100
1.43
0.53
1.4
2.2
8.02
4.30
iu/ml
—
5
27
152
1433
1.17
0.53
4.0
3.4
—
—
—
0
0
55
625
0.84
0.49
3.7
2.9
0.00
0.01
estimate
0.50
24
172
30
360
0.81
0.46
1.5
1.5
—
—
—
0
0
10
69
1.47
0.45
1.1
2.0
—
—
—
0
0
6
92
0.64
0.43
1.8
1.7
—
—
—
0
0
5
31
1.63
0.43
1.2
1.6
—
—
—
0
0
10
70
1.45
0.42
1.1
2.3
—
—
—
0
0
25
205
1.25
0.41
9.4
7.5
—
—
—
0
0
5
34
1.48
0.40
2.2
1.6
—
—
—
0
0
203
1976
1.20
0.39
4.9
5.0
4.21
4.66
mmol/l
8.34
194
1862
40
348
1.18
0.38
2.9
2.8
0.55
0.76
ug/l
1.16
22
199
9
68
1.34
0.38
1.1
1.1
—
6.08
—
0
9
5
37
1.36
0.37
2.2
1.5
—
—
—
0
0
6
42
1.44
0.36
1.3
1.5
—
—
—
0
0
116
1095
1.12
0.34
4.1
3.7
0.00
0.00
estimate
-0.00
28
220
15
187
0.79
0.33
1.3
1.8
2.77
3.55
mmol/l
—
9
137
6
47
1.28
0.32
1.5
1.4
1.32
0.97
nmol/l
—
6
41
66
609
1.12
0.28
4.2
3.7
0.00
0.01
estimate
0.50
26
202
17
140
1.23
0.28
1.2
1.3
—
45.76
—
0
5
19
159
1.21
0.27
2.1
2.5
—
14.49
—
0
9
116
1105
1.10
0.27
4.2
3.7
0.00
0.00
estimate
-0.00
28
221
17
141
1.22
0.27
1.0
1.0
—
—
—
0
0
10
77
1.31
0.26
1.3
1.5
—
—
—
0
0
193
1886
1.13
0.26
6.1
5.3
1.89
1.88
mu/l
0.04
183
1759
117
1117
1.09
0.26
4.2
3.8
0.00
0.00
estimate
-0.00
27
209
203
1992
1.14
0.24
5.6
5.5
2.52
2.73
mmol/l
2.78
194
1868
201
1973
1.13
0.23
4.8
4.9
1.29
1.46
mmol/l
9.87
189
1850
35
316
1.13
0.22
1.7
2.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
122.73
—
0
11
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
9.3
—
35.80
—
0
5
61
572
1.09
0.19
4.7
4.8
1.50
1.81
ug/l
0.63
55
520
8
68
1.18
0.17
1.3
1.6
—
—
—
0
0
8
72
1.11
0.16
1.4
1.2
—
—
—
0
0
64
607
1.07
0.16
4.2
4.1
6.42
11.33
mg/mmol
0.97
42
378
8
73
1.10
0.16
1.4
1.2
—
—
—
0
0
18
159
1.14
0.15
1.3
1.4
—
—
—
0
0
10
85
1.18
0.12
1.5
1.6
44.14
59.81
ug/l
—
5
71
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
1.3
—
—
—
0
0
5
65
0.76
0.08
1.0
1.3
—
—
—
0
0
9
87
1.04
0.07
1.9
1.5
—
—
—
0
0
36
345
1.05
0.06
1.8
2.3
—
—
—
0
0
187
1856
1.04
0.05
6.6
5.9
35.21
38.68
mmol/mol
4.10
171
1755
47
459
1.03
0.03
5.8
4.2
22.64
21.86
%
0.09
15
197
83
840
0.98
0.02
3.8
3.5
0.00
0.01
estimate
0.50
23
185
191
1901
1.03
0.02
5.5
4.8
6.09
5.85
mmol/l
1.39
182
1768
14
146
0.96
0.00
1.5
1.5
638.78
1021.22
mu/l
—
8
124
24
242
0.99
0.00
4.0
4.7
30.84
31.53
%
0.11
19
161
13
134
0.97
0.00
1.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
75
0.93
-0.00
1.4
1.3
—
—
—
0
0
6
62
0.97
-0.00
1.3
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
5.86
—
0
5
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
66.69
—
0
7
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.6
—
5.82
—
0
5
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
0.15
—
0
7
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
10.42
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
0.02
—
0
6
6
64
0.94
-0.00
2.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_HEREDHAEMOLYTICANAEMIAOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HEREDHAEMOLYTICANAEMIAOTHER | 2.308 [1.7, 3.13] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.442 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 731 females with D3_HEREDHAEMOLYTICANAEMIAOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HEREDHAEMOLYTICANAEMIAOTHER | 2.124 [1.51, 2.99] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 684 males with D3_HEREDHAEMOLYTICANAEMIAOTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_HEREDHAEMOLYTICANAEMIAOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.155% | 0.381% |
| 5 | 1.246% | 2.119% |
| 10 | 3.404% | 5.639% |
| 15 | 6.755% | 10.52% |
| 20 | 11.738% | 17.51% |
Relationships between endpoints
↥Index endpoint: D3_HEREDHAEMOLYTICANAEMIAOTHER – Other hereditary haemolytic anaemias
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data